Skip to content

Investigation of Preoperative Frailty in Elderly Patients With Colorectal Cancer and Correlation Between Preoperative Frailty and Early Postoperative Prognosis

Investigation of Preoperative Frailty in Elderly Patients With Colorectal Cancer and Correlation Between Preoperative Frailty and Early Postoperative Prognosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05915637
Enrollment
336
Registered
2023-06-23
Start date
2021-09-01
Completion date
2022-11-01
Last updated
2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

To investigate and analyze the status of preoperative frailty and its influencing factors in elderly patients with colorectal cancer using FRALL scale and other related scales, and to explore the correlation between preoperative frailty and early prognosis in elderly patients with colorectal cancer, so as to attract the attention of medical staff to preoperative frailty in this population and provide a preliminary research basis for the study of frailty intervention in these patients.

Interventions

None listed

Sponsors

Zunyi Medical College
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age ≥60 years old; 2. Colorectal cancer was diagnosed according to the Chinese Guidelines for Diagnosis and Treatment of Colorectal Cancer (2020 edition) and planned to undergo elective laparoscopic radical resection of colorectal cancer; 3. able to complete physical assessment without communication barriers; 4. voluntarily participated in this study after informed consent.

Exclusion criteria

1. taking antidepressants, levodopa, donepezil hydrochloride and other drugs; 2. patients with preoperative colorectal cancer surgery or neoadjuvant therapy; 3. patients with TNM stage Ⅳ; 4. complicated with other malignant tumors except primary skin cancer or melanoma.

Design outcomes

Primary

MeasureTime frameDescription
Fatigue Assessment7 daysStatus of frailty will be assessed by FRALL Scale

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026